Company CVAbout Alivus Life Sciences Ltd 
Alivus Life Sciences Ltd
Small Cap
Pharmaceuticals & Biotechnology
Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 24.51 Cr
Number of Shares
12.25 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
03-Aug-2021
12.25
24.51
14722222
2
Public Issue
06-Apr-2021
10.78
21.56
98004500
2
Bonus Issue
26-Mar-2021
98
1.96
7840360
2
Stock Split
09-Jul-2018
19.6
1.96
1500000
2
Preferential basis
29-Jun-2018
4.6
0.46
450090
2
Loan Conversion
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 11 Schemes (3.87%)
FIIs
Held by 66 FIIs (6.84%)
Promoter with highest holding
Nirma Limited (74.91%)
Highest Public shareholder
Polar Capital Funds Plc - Healthcare Opportunities (2.79%)
Individual Investors Holdings
10.14%
Board of Directors
Management
Designation
Remuneration
Glenn Saldanha
Chairman & Non Executive Dir.
0
V S Mani
Non Executive Director
0
Yasir Yusufali Rawjee
Managing Director & CEO
5.5 cr
Vinod Naik
E D & Wholetime Director
1.29 cr
Sridhar Gorthi
Independent Non Exe. Director
18.0 lacs
Manju Agarwal
Independent Non Exe. Director
12.0 lacs
Taruvai Laxminarayanan Easwar
Independent Non Exe. Director
10.0 lacs
Gita Nayyar
Independent Non Exe. Director
12.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
COST OF MATERIALS CONSUMED
1010.093
0%
COST OF MATERIALS CONSUMED
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
588 Cr
(Quarterly Results - Sep 2025)
Net Profit:
130 Cr
Pharmaceuticals & Biotechnology
INR 10,831 Cr (Small Cap)
20.00
34
0.58%
-0.20
17.59%
3.53
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
